Back
Corcept Therapeutics Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Buy
70
CORT
Corcept Therapeutics
Last Price:
$55.28
Seasonality Move:
9.2%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.38 | Buy |
| 20-day SMA: | 51.85 | Buy |
| 50-day SMA: | 54.96 | Buy |
| 200-day SMA: | 39.26 | Buy |
| 8-day EMA: | 53.04 | Buy |
| 20-day EMA: | 52.88 | Buy |
| 50-day EMA: | 52.5 | Buy |
| 200-day EMA: | 42.45 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 58.22 | Buy |
| Chaikin Money Flow: | 695993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.37 - 55.17) | Buy |
| Bollinger Bands (100): | (41 - 56.4) | Buy |
Corcept Therapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 55.31 while CORT 8-day simple moving average is 52.38, which is a Buy signal.
-
The stock price of CORT is 55.31 while Corcept Therapeutics 20-day SMA is 51.85, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 54.96 while CORT share price is 55.31, making it a Buy technically.
-
CORT stock price is 55.31 and Corcept Therapeutics 200-day simple moving average is 39.26, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
70
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $55.31. The Score for CORT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
5.8B
Price in USD:
55.31
Share Volume:
742.4K
Corcept Therapeutics 52-Week Range
52-Week High:
62.22
52-Week Low:
20.84
Buy
70
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 55.31 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 55.31 while CORT 8-day exponential moving average is 53.04, which is a Buy signal.
-
The stock price of CORT is 55.31 while Corcept Therapeutics 20-day EMA is 52.88, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 52.50 while CORT share price is 55.31, making it a Buy technically.
-
CORT stock price is 55.31 and Corcept Therapeutics 200-day simple moving average is 42.45, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $1.54 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Corcept Therapeutics is a Sell
-
Corcept Therapeutics Relative Strength Index (RSI) is 58.22, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (50.37 - 55.17), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (41 - 56.4), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.